Nurix Therapeutics NRIX
NASDAQ NRIX
$23.71 +0.03 (+0.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Other Non-Current Liabilities (2019 - 2021)

Updated

Nurix Therapeutics (NRIX) reported Other Non-Current Liabilities of $796,000 for fiscal Q3 2021 (quarter ended Aug 31, 2021), down 8.3% from $868,000 a year earlier and down 4.9% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends

At the end of FY2020 (ended Nov 30, 2020), Nurix Therapeutics posted Other Non-Current Liabilities of $850,000, down 51.1% from FY2019.

  • By fiscal year, Other Non-Current Liabilities came in at $1.74 million in FY2019.
  • Per Business Quant data, the three fiscal quarters before Q3 2021 came in at $837,000 (Q2 2021), $832,000 (Q1 2021) and $850,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 796,000.00
May 31, 2021 837,000.00
Feb 28, 2021 832,000.00
Nov 30, 2020 850,000.00
Aug 31, 2020 868,000.00
Nov 30, 2019 1.74 Mn
API Access

Nurix Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NRIX&period=max&api_key=YOUR_API_KEY